English
BIMM-SOL project (2016-2018)
The goal of this project is to commercialize processes for analyzing molecular microbial biomarkers in the qualitative biological diagnosis of soils.
About the project: https://librairie.ademe.fr/recherche-et-innovation/2272-bimm-sol.html
Funding:
DIAMA project (2016-2021)
The DIAMA project is assessing and validating the Deeplex® Myc-TB test in Africa and Europe. This rapid molecular test (based on mass sequencing) detects and genotypes mycobacteria and predicts antituberculosis drug resistance in Mycobacterium tuberculosis complex strains.
Partners:
- Centre National Hospitalier de Pneumo-Phtisiologie - Benin,
- Prins Leopold Instituut voor Tropische Geneeskunde - Belgium (Bruxelles),
- Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) - Mali,
- London School of Hygiene and Tropical Medicine (LSHTM) - United Kingdom (London),
- Service de Pneumophtisiologie de l’Hôpital National Ignace Deen - Guinea,
- Jimma University - Ethiopia,
- Université Catholique de Louvain (UCL) - Belgium (Louvain),
- The Bamenda Center for Health Promotion and Research - Cameroun,
- Institute National of Research Biomedical of Zaire (INRB) - Congo,
- Damien Foundation - Belgium (Bruxelles),
- Rwanda Biomedical Center (RBC) - Rwanda,
- University Cheikh Anta Diop - Senegal,
- World Health Organization (WHO).
Funding:
FLU-MICROBIOT project (2015-2018)
The goal of this project is to understand the role of microbiotas and the gastrointestinal and respiratory tracts in influenza co-infections.
Partners:
-
- INSERM - France (Lille),
- CNRS - France (Lille),
- Université Lille 1 Sciences et Technologie - France (Lille),
- Institut Pasteur de Lille - France (Lille),
- Minas Gerais Federal University - Brasil.
Funding:
BioDISSPOL project (2015-2018)
Development of microbial biomarkers for the identification and monitoring of sites polluted by chlorinated solvents.
Partners:
- BRGM - France (Lesquin),
- Université de Strasbourg - France (Strasbourg).
Funding:
MICROTYPE project (2014-2018)
This project underpins the worldwide surveillance of infectious agents like Brucella (the bacterium responsible for brucellosis) via the development of typing kits and databases.
Partners:
Funding:
Our turnkey solutions to exploit the potential of metagenomics
You are looking for:
|
 |
Discover our turnkey solutions:
DNA & RNA extractionBenefit from our optimized, standardized and reproductible protocols for all types of initial matrix (including negative and positive controls). |
Microbial biomassEstimate the quantity of gDNA corresponding to the microbial community in your samples, by using complex standard curves that are appropriate for your field of interest (intestinal, cutaneous microbiota etc.). |
|
|
|
||
Metabiote®Use a standardized approach for the targeted analysis of ubiquitous genes (16S rRNA, ITS 1/2, 18S rRNA, etc.), in order to:
|
Shotgun metagenomicsGet an overview of the organisms present in your samples such as:
|
|
|
|
||
MetatranscriptomicsCharacterize changes in gene expression within microbial communities, in order to better understand their main functions and how they adapt to their environment. |
Bacterial countsDetermine or validate changes in the abundance of specific bacteria using qPCR. Ask for a feasability study on your specific target or benefit from our «ready-to-qPCR» assays. |
|
About us
GenoScreen is a French biotech company specialised in genomics and bioinformatics. We offer innovative services and solutions based on the characterization and exploitation of DNA/RNA molecules.
GenoScreen works on all kinds of genomes (Human, animal, plant and microbial) and delivers solutions for research groups from the private and public sectors.
Our microbial expertise continues to deepen since 2008, alongside the development of optimized and standardized, analytical protocols by our R&D team.
As the French leader in this sector, GenoScreen offers solutions that address your needs to characterize and understand microbiota.
Work with GenoScreen and benefit from:
|
 |
They used our services:
- Laura Di Lodovico et al, Anorexia nervosa and gut microbiota: A systematic review and quantitative synthesis of pooled microbiological data, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2020 Sept; 110114
- Céline L. Pouille et al. Chicory root flour – A functional food with potential multiple health benefits evaluated in a mice model, Journal of Functional Foods, 2020 Nov; 74:104174
- Luen-Luen Li et al, Impacts of microplastics exposure on mussel (Mytilus edulis) gut microbiota, Science of The Total Environment, 2020 Nov; 745:141018
- Julia Mougin et al, Development of a mreB-targeted real-time PCR method for the quantitative detection of Vibrio harveyi in seawater and biofilm from aquaculture systems, Aquaculture, 2020 Aug; 525:735337
Custom qPCR service
GenoScreen supports you in developing and optimizing your custom qPCR tests. Our team designs specific assays tailored to your need, whether for detecting genetically modified strains, differentiating species at the desired taxonomic level (strain, species, genus), or analyzing genes of interest (enzymatic function, RT-qPCR, etc.).
Advanced expertise in custom qPCR
In silico design, in vitro validation, and optimization of experimental conditions.
Improved sensitivity, efficiency, and robustness.
Support for implementing the method on your own platforms.
Determination of LOD (limit of detection) and LOQ (limit of quantification), testing on complex matrices.
Primer
design
(In silico)
Specificity testing
Primer
verification
(In silico)
If primers are provided
qPCR test development and optimization
Result analysis
Quantification or detection
Interpretation and reporting
Method transfer or delivery as a ready-to-use kit
Extraction ADN optimisée pour chaque matrice
selles, sols, peau, fermentés, etc.
Préparation des librairies
avec contrôles qualités intégrés
Séquençage haut-débit adapté
Analyse bioinformatique
Interprétation & Restitution
Primer
design
(in silico)
Specificity testing
Primer
verification
(in silico)
If primers are provided
qPCR test development and optimization
Result analysis
Quantification or detection
Interpretation and reporting
Method transfer or delivery as a ready-to-use kit
Adjustment of experimental conditions (temperature, concentrations, cycles)
Determination of LoD and LoQ
Inhibitor screening related to the analyzed matrix
Validation on real samples to ensure robustness and reproducibility
Clearly annotated report from our experts, including explanation of results and limitations
Optional oral presentation to ensure full understanding of outcomes
We assist you in transferring the developed test onto your own qPCR platforms.
We also offer custom "ready-to-use" kit formulation for use in your labs or by your project partners.
Why choose GenoScreen?
Scientific and regulatory expertise
With a rigorous and transparent approach, we develop qPCR methods compliant with EFSA standards, particularly for residual DNA and GMM detection in finished products. Each step is validated under high-quality standards. Our methods are designed in compliance with ISO 9001 and can be adapted to GCLP and GMP requirements.
Accurate and actionable results
We provide complete reporting formats, including absolute or relative quantification and analytical validation according to your needs. Each project comes with detailed reports outlining development and optimization steps. We ensure regular interactions throughout the project with Go/No-Go decision checkpoints to guarantee optimal quality control and full transparency.
Flexibility and personalized support
We design custom primers and probes (MGB, TaqMan, etc.) to ensure performance and specificity. Our client support is tailored, with regular communication, fast troubleshooting, and close monitoring at every stage. Our solutions are compatible with a wide variety of sample types: powders, liquids, environmental, or biological matrices.
Responsive and efficient service
Experience fast turnaround times (6 to 8 weeks) for qualitative or quantitative analyses, fully tailored to your needs. Receive personalized support with a dedicated contact for smooth follow-up from design to results interpretation.
Our custom qPCR services are applicable across multiple sectors:
Human Health & Microbiota : Quantification of specific strains and gene-of-interest quantification
Agri-food Industry : Detection of residual DNA, validation of manufacturing processes, regulatory dossiers (e.g., EFSA) for genetically modified strains
Biotechnology : Monitoring of microbial cultures, quality control of finished products, rapid diagnostics for recurrent contaminants
Detection of residual DNA from genetically modified production strains in finished products
Detection of residual plasmid DNA after fermentation tank cleaning
Detection of target bacterial strains in environmental samples
Gene quantification under different culture conditions
Subcategories
GenoScreen
Partners
At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.
A network of strategic partners
We actively collaborate with:
Research institutes, universities and hospitals
Competitive clusters specialized in biotechnology and healthcare
Public funding bodies
A co-development strategy
Our research projects are carried out with recognized partners in France and abroad. Together, we can :
- Co-develop innovative genomics and bioinformatics solutions
- Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
- Test and validate our technologies in a variety of environments
- Launch the implementation of concrete solutions for health, agriculture and the environment
Why collaborate with GenoScreen?
- Access to an innovative sequencing technology platform
- Access to recognized expertise in bioinformatics analysis and biomarkers
- Benefit from our ability to manage collaborative R&D projects
- Strive for health, agriculture and environment
Join our network of partners
Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.
Frequently asked questions
What kind of partners work with GenoScreen?
GenoScreen works with academic laboratories, biotech companies and clusters.
What are the benefits of these partnerships?
They help us co-develop technologies, co-finance projects and accelerate innovation.
How can I propose a partnership?
You can contact us via our contact form to discuss your project and identify a potential collaboration.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.